M
Mercedes Lassus
Publications - 4
Citations - 1056
Mercedes Lassus is an academic researcher. The author has contributed to research in topics: Aromatase inhibitor & Letrozole. The author has an hindex of 2, co-authored 3 publications receiving 1040 citations.
Papers
More filters
Journal ArticleDOI
Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy for Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Study of the International Letrozole Breast Cancer Group
Henning T. Mouridsen,Mikhail Gershanovich,Yan Sun,Ramon Perez-Carrion,Corrado Boni,Alain Monnier,Justus Apffelstaedt,Robert S. Smith,Harm Sleeboom,Fritz Jänicke,Anna Pluzanska,Magdolna Dank,Dominique Becquart,Poonamalle P. Bapsy,Eeva Salminen,Raymond Snyder,Mercedes Lassus,J. Arnold Verbeek,Beatrix Staffler,H. A. Chaudri-Ross,Margaret Dugan +20 more
TL;DR: Letrozole was significantly superior to tamoxifen in TTP, TTF, ORR, and clinical benefit rate, and its results support its use as first-line endocrine therapy in postmenopausal women with advanced breast cancer.
Journal ArticleDOI
Phase 1 study of carboplatin in patients with advanced cancer, intermittent intravenous bolus, and 24-hour infusion.
TL;DR: Patients with poor performance status, preexisting renal dysfunction, a third fluid space, or bone metastases seemed to develop increased hematologic toxicity, and the recommended phase 2 dose for good risk patients is 400 mg/m2 IV bolus and for poor risk patients 270 mg/ m2IV bolus.
Superior E fficacy o f L etrozole V ersus T amoxifen a s First-Line T herapy f or P ostmenopausal W omen W ith Advanced B reast C ancer: R esults o f a P hase I II S tudy o f the I nternational L etrozole B reast C ancer G roup
Henning T. Mouridsen,Mikhail Gershanovich,Yan Sun,Corrado Boni,Alain Monnier,Justus Apffelstaedt,Robert S. Smith,Harm Sleeboom,Anna Pluzanska,Magdolna Dank,Dominique Becquart,Poonamalle P. Bapsy,Eeva Salminen,Raymond Snyder,Mercedes Lassus,J. Arnold Verbeek,Beatrix Staffler,H. A. Chaudri-Ross,Margaret Dugan +18 more
TL;DR: In this paper, the authors compared the efficacy and tolerability of tamoxifen with that of letrozole, an oral aromatase inhibitor, with tamioxifen as first-line therapy in postmenopausal women with advanced breast cancer.
Journal ArticleDOI
[Nephrotic syndrome due to preeclampsia: Presentation, management and clinical evolution observed in 5 years experience].
Albertina María Ghelfi,Florencia Garavelli,B. Meres,F. R. Dipaolo,Mercedes Lassus,Alexandre Pahud,Maikel Leyva Vázquez,Jorge Guillermo Kilstein,R. F. Mamprin D'Andrea +8 more
TL;DR: In this paper , the authors describe the clinical presentation, analytical features, medical management, and progress of women with pre-eclampsia due to PE in a descriptive, retrospective study, conducted from 1/1/2017 to 1/01/2022 (5 years).